Published in Gene Therapy Weekly, February 5th, 2009
"STO-609, used at a 25 mc M concentration known to fully inhibit...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.